Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Stuelten Website

Christina H. Stuelten, M.D., Ph.D.

Selected Publications

1)  Weiger MC, Vedham V, Stuelten CH, Shou K, Herrera M, Sato M, Losert W, Parent CA.
Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.
PLoS ONE. 8: e58859, 2013.
[Journal]
2)  Stuelten CH, Cervoni-Curet FN, Busch JI, Sutton E, Webster JD, Kavalukas SL, Wakefield LM, Barbul A, Niederhuber JE.
SDF-1a mediates wound-promoted tumor growth in a syngeneic orthotopic mouse model of breast cancer.
PLoS ONE. 8: e60919, 2013.
[Journal]
3)  Kohn EA, Yang YA, Du Z, Nagano Y, Van Schyndle CM, Herrmann MA, Heldman M, Chen JQ, Stuelten CH, Flanders KC, Wakefield LM.
Biological responses to TGF-ß in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression.
Mol. Cancer Res. 10: 1389-99, 2012.
[Journal]
4)  Fleming JM, Miller TC, Kidacki M, Ginsburg E, Stuelten CH, Stewart DA, Troester MA, Vonderhaar BK.
Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.
Breast Cancer Res. 14: R97, 2012.
[Journal]
5)  Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W, Zerfas P, Zhigang D, Wright EC, Stuelten C, Sun P, Lonning S, Skarulis M, Sumner AE, Finkel T, Rane SG.
Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.
Cell Metab. 14: 67-79, 2011.
[Journal]
6)  Peskin AP, Hoeppner DJ, Stuelten CH.
Segmentation and Cell Tracking of Breast Cancer Cells (ISVC).
Volume 2011 (1). p. 381-391. [Meeting Proceeding]
7)  Kohn EA, Du Z, Sato M, Van Schyndle CM, Welsh MA, Yang YA, Stuelten CH, Tang B, Ju W, Bottinger EP, Wakefield LM.
A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland.
Breast cancer research : BCR. 12: R83, 2010.
[Journal]
8)  Pastar I, Stojadinovic O, Krzyzanowska A, Barrientos S, Stuelten C, Zimmerman K, Blumenberg M, Brem H, Tomic-Canic M.
Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers.
Mol. Med. 16: 92-101, 2010.
[Journal]
9)  Stuelten CH, Mertins SD, Busch JI, Gowens M, Scudiero DA, Burkett MW, Hite KM, Alley M, Hollingshead M, Shoemaker RH, Niederhuber JE.
Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel.
Stem Cells. 28: 649-60, 2010.
[Journal]
10)  Stuelten CH, Salomon DS.
miR-31 in cancer: location matters.
Cell Cycle. 9: 4608-9, 2010.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/8/2013.